What is polpharma biologics? Polpharma Biologics is a fast-growing unit within Poland, developing and manufacturing new biopharmaceuticals as molecular entities (NMEs) or biosimilars, as well as delivering biopharmaceutical CDMO services.Who is the ceo of polpharma group? Markus Sieger is continuing his role of CEO Polpharma Group focusing on coordination of the new, global strategy to ensure the dynamic growth and development of the entire Polpharma Group in all markets. PRZEWODNIK DOBRYCH PRAKTYK – ZACHĘCAMY DO LEKTURY!What biosimilars does polpharma biologics have in the pipeline? Polpharma Biologics currently has 7 biosimilars in its pipeline including a ranibizumab molecule (FYB201), which was developed in partnership with Bioeq for the treatment of wet age-related macular degeneration. The company is also in the process of developing a natalizumab molecule in collaboration with Sandoz.How to contact zakłady farmaceutyczne polpharma? 3. Zakłady Farmaceutyczne Polpharma S.A. have appointed a data protection officer who may be contacted in writing at the following address: Data Protection Officer, Zakłady Farmaceutyczne Polpharma S.A., ul. Bobrowiecka 6, 00-728 Warszawa, via email at [email protected] or by phone at + 48 22 364 63 11.
Company Description: POLPHARMA BIOLOGICS WARSAW SP Z O O is located in Ożarów Mazowiecki, mazowieckie, Poland and is part of the Pharmaceutical and Medicine Manufacturing Industry. POLPHARMA BIOLOGICS WARSAW SP Z O O has 15 employees at this location and generates $349,512 in sales (USD).